Literature DB >> 23456643

Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.

Mingyuan Liu1, Xiaojun Hou, Ping Zhang, Yong Hao, Yiting Yang, Xiongfeng Wu, Desheng Zhu, Yangtai Guan.   

Abstract

Multiple sclerosis (MS) is the most prevalent demyelinating disease and the principal cause of neurological disability in young adults. Recent microarray gene expression profiling studies have identified several genetic variants contributing to the complex pathogenesis of MS, however, expressional and functional studies are still required to further understand its molecular mechanism. The present study aimed to analyze the molecular mechanism of MS using microarray analysis combined with bioinformatics techniques. We downloaded the gene expression profile of MS from Gene Expression Omnibus (GEO) and analysed the microarray data using the differentially coexpressed genes (DCGs) and links package in R and Database for Annotation, Visualization and Integrated Discovery. The regulatory impact factor (RIF) algorithm was used to measure the impact factor of transcription factor. A total of 1,297 DCGs between MS patients and healthy controls were identified. Functional annotation indicated that these DCGs were associated with immune and neurological functions. Furthermore, the RIF result suggested that IKZF1, BACH1, CEBPB, EGR1, FOS may play central regulatory roles in controlling gene expression in the pathogenesis of MS. Our findings confirm the presence of multiple molecular alterations in MS and indicate the possibility for identifying prognostic factors associated with MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456643     DOI: 10.1007/s11033-012-2449-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  35 in total

1.  Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis.

Authors:  J Tan; T Town; D Paris; A Placzek; T Parker; F Crawford; H Yu; J Humphrey; M Mullan
Journal:  J Neuroimmunol       Date:  1999-06-01       Impact factor: 3.478

Review 2.  The prevalence of multiple sclerosis in the world: an update.

Authors:  G Rosati
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

3.  Gene co-expression network topology provides a framework for molecular characterization of cellular state.

Authors:  Scott L Carter; Christian M Brechbühler; Michael Griffin; Andrew T Bond
Journal:  Bioinformatics       Date:  2004-05-06       Impact factor: 6.937

4.  Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data.

Authors:  Antonio Reverter; Nicholas J Hudson; Shivashankar H Nagaraj; Miguel Pérez-Enciso; Brian P Dalrymple
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

5.  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Authors:  D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

6.  Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells.

Authors:  Malabendu Jana; Subhajit Dasgupta; Xiaojuan Liu; Kalipada Pahan
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

Review 7.  Multiple sclerosis therapies: molecular mechanisms and future.

Authors:  Paulo Fontoura; Hideki Garren
Journal:  Results Probl Cell Differ       Date:  2010

8.  Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy.

Authors:  W R Tyor; J D Glass; N Baumrind; J C McArthur; J W Griffin; P S Becker; D E Griffin
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

Review 9.  Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.

Authors:  Marcin P Mycko; Ruben Papoian; Ursula Boschert; Cedric S Raine; Krzysztof W Selmaj
Journal:  Clin Neurol Neurosurg       Date:  2004-06       Impact factor: 1.876

10.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

View more
  4 in total

1.  Identification of Novel Key Genes and Pathways in Multiple Sclerosis Based on Weighted Gene Coexpression Network Analysis and Long Noncoding RNA-Associated Competing Endogenous RNA Network.

Authors:  Yuehan Hao; Miao He; Yu Fu; Chenyang Zhao; Shuang Xiong; Xiaoxue Xu
Journal:  Oxid Med Cell Longev       Date:  2022-03-02       Impact factor: 6.543

2.  DCGL v2.0: an R package for unveiling differential regulation from differential co-expression.

Authors:  Jing Yang; Hui Yu; Bao-Hong Liu; Zhongming Zhao; Lei Liu; Liang-Xiao Ma; Yi-Xue Li; Yuan-Yuan Li
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

3.  Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.

Authors:  Dianelys Gonzalez-Pena; Scott E Nixon; Jason C O'Connor; Bruce R Southey; Marcus A Lawson; Robert H McCusker; Tania Borras; Debbie Machuca; Alvaro G Hernandez; Robert Dantzer; Keith W Kelley; Sandra L Rodriguez-Zas
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

4.  Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms.

Authors:  Sherry Freiesleben; Michael Hecker; Uwe Klaus Zettl; Georg Fuellen; Leila Taher
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.